PsyQ: Journal Club

PsyQ
  • 0.0（0則評分）
  • 科學
  • 每週更新

This is an AI generated podcast. Stay updated on the foundational research shaping our field. Psych Bytes provides concise, expert-reviewed summaries of landmark papers for busy psychiatry residents and clinicians. We leverage AI tools like NotebookLM to kickstart the summary process, followed by human review and contextualization to ensure accuracy and clinical relevance. Your quick guide to essential psychiatric literature. These are merely summaries meant to improve access through convenience, please be mindful that inaccuracies may be present - please refer to original source material for the most accurate and representative information. upathak.substack.com

  1. Brain and Blood Biomarkers in MDD - PsyQ Episode 39

    3月2日

    Brain and Blood Biomarkers in MDD - PsyQ Episode 39

    This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

    13 分鐘
  2. In-Utero Antipsychotic Medication Exposure - PsyQ Episode 38

    2月16日

    In-Utero Antipsychotic Medication Exposure - PsyQ Episode 38

    This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

    15 分鐘
  3. The Psychic Tourniquet: Ultra-Low-Dose Buprenorphine for Acute Suicidality - PsyQ Episode 37

    2月7日

    The Psychic Tourniquet: Ultra-Low-Dose Buprenorphine for Acute Suicidality - PsyQ Episode 37

    In this episode of PsyQ, we confront the "zone of danger" in acute suicidality—the critical lag period where standard antidepressants often fail to address immediate "psychache". Anchored by the seminal Yovell et al. (2016) randomized controlled trial, we explore the neurobiological overlap between physical and social pain , testing the hypothesis that ultra-low-dose buprenorphine (starting at 0.1 mg) can modulate the endogenous opioid system to treat separation distress directly. We dissect the study's groundbreaking findings—including a significant reduction in suicidal ideation distinct from depression improvement and robust efficacy in patients with Borderline Personality Disorder —while rigorously outlining the safety parameters, zero-withdrawal protocols, and the critical clinical distinction between treating specific depressive symptoms and soothing the primal agony of the PANIC/GRIEF system. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

    17 分鐘
  4. Cannabis Use Disorder and Adolescent Suicide Risk - PsyQ Episode 36

    2月2日

    Cannabis Use Disorder and Adolescent Suicide Risk - PsyQ Episode 36

    In this episode of PsyQ, we review a large national inpatient study examining the association between cannabis use disorder (CUD) and suicide attempts/self-harm among hospitalized adolescents in the United States. Using data from more than 800,000 adolescent hospitalizations, the study demonstrates that CUD is independently associated with approximately 40% increased odds of suicide attempts and self-harm, even after controlling for psychiatric and substance use comorbidities. The data further highlight depression as a key moderator, with adolescents experiencing both CUD and depression showing markedly higher suicide risk compared to those with either condition alone. The findings reinforce the importance of routine substance use screening, suicide risk assessment across all inpatient settings (not just psychiatric units), and implementation of dual-diagnosis treatment approaches targeting both cannabis use and co-occurring psychiatric illness. These results are particularly relevant given rising cannabis use among adolescents and shifting risk perceptions related to legalization and accessibility. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

    15 分鐘
  5. STEP-BD: The Efficacy of Adjunctive Antidepressants in Bipolar Depression

    1月25日

    STEP-BD: The Efficacy of Adjunctive Antidepressants in Bipolar Depression

    In this episode of PsyQ, we review the landmark STEP-BD randomized controlled trial evaluating the effectiveness of adjunctive antidepressant treatment for bipolar depression. We analyze the study's methodology, specifically the use of equipoise-stratified randomization to mirror routine clinical care and the selection of "durable recovery"—defined as eight consecutive weeks of euthymia—as the primary outcome measure. The discussion focuses on the key data points demonstrating that the addition of standard antidepressants (bupropion or paroxetine) to mood stabilizers provided no statistically significant benefit over placebo in achieving durable recovery. Furthermore, we examine the safety findings, which indicated that adjunctive antidepressant use was not associated with an increased risk of treatment-emergent affective switch compared to mood stabilizers alone. References Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression. N Engl J Med. 2007;356(17):1711-1722. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

    13 分鐘
  6. TMS in Older Veterans with MDD - PsyQ Episode 34

    1月18日

    TMS in Older Veterans with MDD - PsyQ Episode 34

    This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

    15 分鐘
  7. Switch vs. Augment: Rewriting the Rules for Geriatric TRD - PsyQ Episode 33

    1月10日

    Switch vs. Augment: Rewriting the Rules for Geriatric TRD - PsyQ Episode 33

    In this episode of PsyQ, we perform a forensic analysis of the landmark OPTIMUM trial, a study that fundamentally reshapes the treatment algorithm for resistant depression in older adults. We dissect the head-to-head battle between switching antidepressants versus augmentation, revealing why aripiprazole claims the crown for efficacy while exposing a counterintuitive and critical safety signal regarding bupropion-induced falls. Beyond the clinical pearls, we guide you through the statistical machinery under the hood—specifically how the Benjamini-Hochberg procedure saved the study's primary finding—and introduce the "Rule of Three," a data-driven threshold that suggests exactly when clinicians should stop cycling medications and pivot to interventional psychiatry. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

    17 分鐘
  8. Combination Antidepressants in Acute MDD: How Much Better Is “Better”? - PsyQ Episode 32

    1月5日

    Combination Antidepressants in Acute MDD: How Much Better Is “Better”? - PsyQ Episode 32

    This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

    13 分鐘
顯示全部 (39)

簡介

This is an AI generated podcast. Stay updated on the foundational research shaping our field. Psych Bytes provides concise, expert-reviewed summaries of landmark papers for busy psychiatry residents and clinicians. We leverage AI tools like NotebookLM to kickstart the summary process, followed by human review and contextualization to ensure accuracy and clinical relevance. Your quick guide to essential psychiatric literature. These are merely summaries meant to improve access through convenience, please be mindful that inaccuracies may be present - please refer to original source material for the most accurate and representative information. upathak.substack.com

資訊

  • 頻道
    PsyQ
  • 創作者
    Stay updated on the foundational research shaping our field.
  • 活躍年代
    2025年 - 2026年
  • 集數
    39
  • 年齡分級
    兒少適宜
  • 版權
    © Ujval Pathak
  • 節目網站
    PsyQ: Journal Club

「PsyQ」的更多內容

你可能也會喜歡